Yanan Zhu
Stock Analyst at Wells Fargo
(0)
# 4564
Out of 5,329 analysts
89
Total ratings
20.37%
Success rate
-17.17%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
RGLS Regulus Therapeutics | Downgrades: Equal-Weight | 9 | 7.85 | 14.65% | 2 | May 1, 2025 | |
SRPT Sarepta Therapeutics | Initiates Coverage On: Overweight | 115 | 62.8 | 83.12% | 1 | Apr 11, 2025 | |
ADAP Adaptimmune Therapeu... | Maintains: Equal-Weight | 2 2 | 0.28 | 435.71% | 2 | Mar 21, 2025 | |
AUTL Autolus Therapeutics | Maintains: Overweight | 8 6 | 1.34 | 347.76% | 3 | Mar 21, 2025 | |
MGX Metagenomi | Maintains: Overweight | 25 20 | 1.47 | 1260.54% | 2 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 12 10 | 3.58 | 179.33% | 2 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 58 50 | 12.54 | 298.72% | 6 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 5 4 | 1.24 | 222.58% | 3 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 35 30 | 14.98 | 100.27% | 2 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 60 50 | 8.66 | 477.37% | 4 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 40 5 | 4.06 | 23.15% | 8 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 20 15 | 1.09 | 1276.15% | 6 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 7 4 | 1.62 | 146.91% | 6 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 17 4 | 0.92 | 334.78% | 4 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 82 77 | 31.79 | 142.21% | 2 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 35 40 | 14.68 | 172.48% | 2 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 70 65 | 37.73 | 72.28% | 1 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 30 | 3.65 | 721.92% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 22 25 | 3.35 | 646.27% | 4 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 50 50 | 32.74 | 52.72% | 3 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 10 | n/a | n/a | 2 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 9 13 | n/a | n/a | 3 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 5 4 | 0.74 | 440.54% | 3 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 30 24 | n/a | n/a | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 450 | 2.3 | 19465.22% | 1 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 125 105 | 19.91 | 427.37% | 2 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 14 10 | 2.42 | 313.22% | 2 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 1 1 | n/a | n/a | 2 | Oct 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 272 326 | 638.88 | -48.97% | 1 | Feb 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 79 70 | n/a | n/a | 2 | Oct 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 48 53 | n/a | n/a | 2 | Aug 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 122 133 | n/a | n/a | 4 | May 7, 2020 |